Vertex Pharma Loss Widens; Tightens FY Guidance - Quick Facts

(RTTNews) - Vertex Pharmaceuticals Inc (VRTX) Tuesday reported third-quarter net loss of $170 million or $0.72 per share compared with a loss of $124 million or $0.54 per share last year.

Excluding items, adjusted loss for the quarter was $0.37 per share compared with a loss of $0.32 per share a year ago.

Revenues for the quarter were $179 million compared with $221.7 million in the prior year.

Analysts polled by Thomson Reuters estimated a loss of $0.62 per share on revenues of $146.2 million for the quarter. Analysts' estimates typically exclude special items.

Looking ahead to the full year, the company now expects adjusted revenues of $525 million to $535 million, from prior guidance of $520 million to $550 million.

Analysts expect revenues of $551.8 million for the year.